Kong X, Liu H, He X, Sun Y, Ge W
We can help you decide
Foundayo (Orforglipron) Approved in 2026, Foundayo is the most recent addition to GLP-1 based treatments for weight loss
One of the peptide products is glucagon-like peptide 1, or GLP-1, which regulates appetite and blood sugar levels
Patients experiencing brain fog typically report: Difficulty concentrating or maintaining focus on tasks Memory problems , particularly with short-term recall or word-finding Mental fatigue or feeling mentally 'sluggish' Reduced processing speed when thinking or responding Confusion or difficulty organising thoughts Lack of mental clarity , often described as thinking through a 'haze' These symptoms can range from mild and intermittent to more persistent and functionally impairing, affecting work performance, daily activities, and quality of life
The medication may still be fine, or it may have degraded past the point of effectiveness